NCT01220609 · BASELINE
Baseline characteristics
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- denoms
- counts
- group Id
- BG000
- value
- 23
- units
- Participants
- groups
- description
- Ixabepilone administered at 40 mg/m2 IV infusion over 3 hours on day 1 of a 21-day cycle until disease progression or adverse effects prohibit further treatment
- id
- BG000
- title
- Ixabepilone
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 7.1
- value
- 55.5
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 5
- title
- 40-49 years
- categories
- measurements
- group Id
- BG000
- value
- 12
- title
- 50-59 years
- categories
- measurements
- group Id
- BG000
- value
- 6
- title
- 60-69 years
- param Type
- NUMBER
- title
- Age, Customized
- unit Of Measure
- participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 23
- title
- Female
- measurements
- group Id
- BG000
- value
- 0
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 22
- title
- Leiomyosarcoma
- categories
- measurements
- group Id
- BG000
- value
- 1
- title
- Carcinosarcoma, malignant mixed Mullerian tumor
- param Type
- NUMBER
- title
- Histologic Type
- unit Of Measure
- participants
- population Description
- Eligible and treated patients
Complete source fields
- denoms
- counts
- group Id
- BG000
- value
- 23
- units
- Participants
- groups
- description
- Ixabepilone administered at 40 mg/m2 IV infusion over 3 hours on day 1 of a 21-day cycle until disease progression or adverse effects prohibit further treatment
- id
- BG000
- title
- Ixabepilone
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 7.1
- value
- 55.5
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 5
- title
- 40-49 years
- categories
- measurements
- group Id
- BG000
- value
- 12
- title
- 50-59 years
- categories
- measurements
- group Id
- BG000
- value
- 6
- title
- 60-69 years
- param Type
- NUMBER
- title
- Age, Customized
- unit Of Measure
- participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 23
- title
- Female
- measurements
- group Id
- BG000
- value
- 0
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 22
- title
- Leiomyosarcoma
- categories
- measurements
- group Id
- BG000
- value
- 1
- title
- Carcinosarcoma, malignant mixed Mullerian tumor
- param Type
- NUMBER
- title
- Histologic Type
- unit Of Measure
- participants
- population Description
- Eligible and treated patients
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice
Triangle